Genomics of Drug Sensitivity in Cancer Dabrafenib
Synonyms GSK2118436, Tafinlar
Targets BRAF
Target pathway ERK MAPK signaling
PubCHEM ID 44462760
Jsmol
Download molecule 44462760
PUBCHEM IUPAC INCHI InChI=1S/C23H20F3N5O2S2/c1-23(2,3)21-30-18(19(34-21)16-10-11-28-22(27)29-16)12-6-4-9-15(17(12)26)31-35(32,33)20-13(24)7-5-8-14(20)25/h4-11,31H,1-3H3,(H2,27,28,29)
Smiles S(=O)(=O)(NC3(=C(F)C(C=1(N=C(C(C)(C)C)SC=1C2(=NC(=NC=C2)N)))=CC=C3))C4(=C(F)C=CC=C4F)
Cluster number 32
calculated LogS -7,001
Molecular weight 519,571
calculated LogP 4,5416
H-Acceptors 7
H-Donors 2
Ro5 violations 1
Druglikeness -3,4961
DrugScore 0,167382270555533
Mutagenic none
Tumorigenic none
Reproductive Effective none
Irritant none
Fish Toxicity High FHMT
Fish Toxicity2 1,5664
Rat Acute Toxicity 2,4329
Acute Oral Toxicity III
Caco-2 Permeability Caco2+
Caco-2 Permeability2 0,8948
P-glycoprotein Substrate Non-substrate
P-glycoprotein Inhibitor Non-inhibitor
P-glycoprotein Inhibitor2 Non-inhibitor
Human Ether-a-go-go-Related Gene Inhibition Weak inhibitor
Human Ether-a-go-go-Related Gene Inhibition2 Non-inhibitor
Tetrahymena Pyriformis Toxicity High TPT
Tetrahymena Pyriformis Toxicity2 0,5538
AMES Toxicity Non AMES toxic
CYP450 2C9 Substrate Non-substrate
CYP450 3A4 Substrate Non-substrate
CYP450 3A4 Inhibitor Inhibitor
CYP450 2C19 Inhibitor Non-inhibitor
CYP450 2C9 Inhibitor Inhibitor
CYP450 2D6 Inhibitor Non-inhibitor
CYP450 1A2 Inhibitor Inhibitor
CYP450 2D6 Substrate Non-substrate
Biodegradation Not ready biodegradable
Carcinogenicity (Three-class) Non-carcinogens
Carcinogens Non-required
Blood-Brain Barrier BBB+
CYP Inhibitory Promiscuity High CYP Inhibitory Promiscuity
Honey Bee Toxicity Low HBT
Renal Organic Cation Transporter Non-inhibitor
Subcellular localization Mitochondria
Human Intestinal Absorption HIA+
Aqueous solubility -3,7726
Information useful only for research purposes.